Peptides in Skincare: What the Data Says About 2026’s Biggest Beauty Trend
Peptides in Skincare: What the Data Says About 2026's Biggest [...]
By Dr. Jane Yoo|2026-06-19T17:05:48+00:00June 19th, 2026|Categories: Aesthetic Innovations|Tags: collagen peptides, copper peptides, GHK-Cu, peptide serum, peptides skincare, what are peptides|Comments Off on Peptides in Skincare: What the Data Says About 2026’s Biggest Beauty Trend
Fear of Overfilling as a Market Force: How It’s Reshaping the Injectables Industry
Fear of Overfilling as a Market Force: How It’s Reshaping [...]
By Dr. Jane Yoo|2026-06-19T16:55:12+00:00June 18th, 2026|Categories: Aesthetic Innovations|Tags: aesthetic industry trends, biostimulator growth, fear of overfilling, filler market 2026, filler reversal demand, hyaluronidase market, injectable minimalism|Comments Off on Fear of Overfilling as a Market Force: How It’s Reshaping the Injectables Industry
GLP-1 Drugs and the Aesthetics Market: What Brands and Investors Need to Know
GLP-1 Drugs and the Aesthetics Market: What Brands and Investors [...]
By Dr. Jane Yoo|2026-06-19T16:55:49+00:00June 18th, 2026|Categories: Aesthetic Innovations|Tags: GLP-1 beauty market, GLP-1 body contouring, injectable market GLP-1, Ozempic aesthetics market, semaglutide skincare, weight loss drug beauty industry|Comments Off on GLP-1 Drugs and the Aesthetics Market: What Brands and Investors Need to Know
Microbiome Skincare in 2026: What the Science Actually Supports
Microbiome Skincare in 2026: What the Science Actually Supports From [...]
By Dr. Jane Yoo|2026-06-19T16:56:39+00:00June 18th, 2026|Categories: Skin Conditions|Tags: microbiome beauty 2026, microbiome skincare, postbiotic skincare, prebiotic skincare, probiotic skincare evidence, skin microbiome dermatology|Comments Off on Microbiome Skincare in 2026: What the Science Actually Supports
Bemotrizinol FDA Approval: What It Means for Sunscreen Formulators and Brands
The Regulatory Event That Changes U.S. Sunscreen Formulation On June [...]
By Dr. Jane Yoo|2026-06-19T16:57:13+00:00June 18th, 2026|Categories: Sun Protection|Comments Off on Bemotrizinol FDA Approval: What It Means for Sunscreen Formulators and Brands
AI in Dermatology: What It Can, and Can’t, Do for Patients
AI in Dermatology: What It Can, and Can’t, Do for [...]
By Dr. Jane Yoo|2026-06-19T17:43:25+00:00June 18th, 2026|Categories: Aesthetic Innovations, Technology|Tags: AI dermatology, AI in medicine, AI melanoma detection, AI skin analysis apps, AI skincare, artificial intelligence skin diagnosis, dermatology AI tools patient|Comments Off on AI in Dermatology: What It Can, and Can’t, Do for Patients
Dr. Jane Yoo
Board-Certified Dermatologist and Mohs Surgeon
Jane Yoo, MD, MPP, is a Korean American board-certified dermatologist and fellowship-trained Mohs surgeon based in Midtown Manhattan. She is a Clinical Assistant Professor at the Icahn School of Medicine at Mount Sinai and the founder of Jane Yoo MD, PLLC and the Clinical Research Center of New York.
Dr. Yoo holds an undergraduate degree from MIT and a Masters of Public Policy from Harvard's Kennedy School of Government. She completed her Mohs micrographic surgery fellowship at Yale. Her clinical and research focus spans aesthetic clinical trials including injectables and laser technology, skincare formulation and sunscreen science, K-Beauty and skin of color, ultrasound guided filler dissolution, artificial intelligence and beauty tech.
Dr. Yoo's research is indexed under ORCID 0000-0002-7112-8963.





